A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 178
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : PT
Long Form : primary tumor
No. Year Title Co-occurring Abbreviation
2022 A Physiologically Based Pharmacokinetic Framework for Quantifying Antibody Distribution Gradients from Tumors to Tumor-Draining Lymph Nodes. PBPK, PK, TDLN
2022 Assessing dynamic metabolic heterogeneity in non-small cell lung cancer patients via ultra-high sensitivity total-body [18F]FDG PET/CT imaging: quantitative analysis of [18F]FDG uptake in primary tumors and metastatic lymph nodes. F-DFM, MLN, MTV, NSCLC, S-DFM, TLG
2022 Different In Situ Immune Patterns between Primary Tumor and Lymph Node in Non-Small-Cell Lung Cancer: Potential Impact on Neoadjuvant Immunotherapy. CT, IM, MLNs, NSCLC
2022 Expression of GLUT4 and FAP in urothelial bladder carcinoma: correlation with angiogenesis and clinicopathological characteristics. CAFs, FAP, GLUT4, LVI, MVD, UC
2022 F18-FDG PET/CT imaging early predicts pathologic complete response to induction chemoimmunotherapy of locally advanced head and neck cancer: preliminary single-center analysis of the checkrad-cd8 trial. EARL, ICIT, pCR, pre-ICIT, ReTu
2022 High Infiltration of CD68+/CD163- Macrophages Is an Adverse Prognostic Factor after Neoadjuvant Chemotherapy in Esophageal and Gastric Adenocarcinoma. EG, NAC, TAMs, TN
2022 Interpatient variability in mesothelin expression necessitates its evaluation before gastric cancer immunotherapy. MSLN, MT
2022 Prediction of Sentinel Lymph Node Biopsy Status in Breast Cancers with PET/CT Negative Axilla. ER, LVI, PET/CT, SLNB
2022 Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™-HER2-FISH workflow. BC, CTCs, FISH, IHC, pts
10  2022 Single-cell RNA-seq dissecting heterogeneity of tumor cells and comprehensive dynamics in tumor microenvironment during lymph nodes metastasis in gastric cancer. GC, MLN
11  2022 [99mTc]Tc-iFAP/SPECT Tumor Stroma Imaging: Acquisition and Analysis of Clinical Images in Six Different Cancer Entities. CAF, DM, FAP, LNM
12  2021 Activation of epithelial-mesenchymal transition process during breast cancer progression - the impact of molecular subtype and stromal composition. BC, EMT, LNM, PR
13  2021 Bcl-xL expression and regulation in the progression, recurrence, and cisplatin resistance of oral cancer. AN, OSCC, RCRT, siRNA
14  2021 Clinical importance of high-mannose, fucosylated, and complex N-glycans in breast cancer metastasis. BC, MSI, TMAs
15  2021 Clinicopathological Features of Low-Grade Appendiceal Mucinous Neoplasms Confined to the Appendix. CDX2, CK20, CK7, LAMNs
16  2021 Discordance of PIK3CA and TP53 mutations between breast cancer brain metastases and matched primary tumors. BC, BM, CSF, NGS
17  2021 Flow cytometry as a diagnostic tool in neuroblastoma. BM, FC, IHC, NB, PB, RF
18  2021 Heterogeneity in Signaling Pathway Activity within Primary and between Primary and Metastatic Breast Cancer. ---
19  2021 Identification and functional analysis of lncRNAs and mRNAs between tumorigenesis and metastasis in CRC. CRC, lncRNAs, MLN, NM
20  2021 Identification of prognostic biomarkers associated with the occurrence of portal vein tumor thrombus in hepatocellular carcinoma. DEGs, ECM, GEO, HCC, PVTT
21  2021 Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analysis. MBC, OS, PFS, TN
22  2021 Mismatch Repair Proteins in Oropharyngeal Squamous Cell Carcinoma: A Retrospective Observational Study. LNM, MMR, OPSCC, OS
23  2021 Occurence of RAS reversion in metastatic colorectal cancer patients treated with bevacizumab. ---
24  2021 Predicting Lymph Node Metastasis Using Computed Tomography Radiomics Analysis in Patients With Resectable Esophageal Squamous Cell Carcinoma. ESCC, IT, LN, LSLN
25  2021 Prognostic significance of OXR1 in urothelial carcinoma: low OXR1 expression is associated with worse survival. ---
26  2021 Reduced expression of innate immunity-related genes in lymph node metastases of luminal breast cancer patients. BCa, LNM
27  2021 Squamousness gain defines pancreatic ductal adenocarcinoma hepatic metastases phenotype, and gemcitabine response. HM, PDAC
28  2021 T cells, B cells, and PD-L1 expression in esophageal and gastric adenocarcinoma before and after neoadjuvant chemotherapy: relationship with histopathological response and survival. EG, IC, NAC, TC
29  2021 The clinical relevance of laboratory prognostic scores for patients with radiosurgically treated brain metastases of non-pulmonary primary tumor. BM, IT, LMR, mGPS, NLR, PLR, TT
30  2021 The immunoexpression of MMP-1 and MMP-13 in eyelid basal cell carcinoma. BCC, BS, iBCC, ISC, MMPs, nBCC, TEC
31  2021 The Tumor Microenvironment in Liver Metastases from Colorectal Carcinoma in the Context of the Histologic Growth Patterns. CRC, DFS
32  2021 The usefulness of [18F]FDG-PET/CT in detecting and managing cancers with unknown primary site depends on histological subtype. SCC
33  2021 Tumor-associated neutrophils (TANs) in human carcinoma-draining lymph nodes: a novel TAN compartment. EMT, OSCC, TANs, TDLNs
34  2020 A Mathematical Model to Predict Diagnostic Periods for Secondary Distant Metastases in Patients with ER/PR/HER2/Ki-67 Subtypes of Breast Cancer. BC, MTSs, sdMTS, TNM
35  2020 Clinical Significance of Nucleoli Cytomorphology Assessment in Patients With Uveal Melanoma. HE
36  2020 Evolution of Estrogen Receptor Status from Primary Tumors to Metastasis and Serially Collected Circulating Tumor Cells. BL, CTCs, DM, ER, PFS
37  2020 Fusion imaging to evaluate the radiographic anatomical relationship between primary tumors and local recurrences in retroperitoneal soft tissue sarcoma. LR, RPS
38  2020 Genetic characterization of a unique neuroendocrine transdifferentiation prostate circulating tumor cell-derived eXplant model. CDX, CRPC, CTCs
39  2020 Genetic profiling of primary and secondary tumors from patients with lung adenocarcinoma and bone metastases reveals targeted therapy options. BM, capSMART, LABM, TKIs
40  2020 Gli1 regulates stemness characteristics in gastric adenocarcinoma. GA, GLI1, IHC, OS
41  2020 Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab. NM, PGP, PR
42  2020 Impact of mRNA-Assessed Molecular Subtype Conversion, Intact and Apoptotic Circulating Tumor Cells on Survival of Metastatic Breast Cancer Patients: Proof of Principle. BC, CTC, MBC, MT, OS, PFS
43  2020 Influx rate constant of 18F-FDG increases in metastatic lymph nodes of non-small cell lung cancer patients. MLN, NSCLC
44  2020 Integrated analysis of optical mapping and whole-genome sequencing reveals intratumoral genetic heterogeneity in metastatic lung squamous cell carcinoma. LNM
45  2020 Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasis. CMS, HR, LM, mCRC
46  2020 Metabolic activity of primary tumour on PET/CT has a relationship with survival in stages I-III small-cell lung carcinoma. PFS and OS, SCLC
47  2020 Multiparametric functional MRI and 18F-FDG-PET for survival prediction in patients with head and neck squamous cell carcinoma treated with (chemo)radiation. DCE, DWI, HNSCC, IVIM, LRFS, OS
48  2020 Paraoxonase-2: A potential biomarker for skin cancer aggressiveness. BCC, NMSCs, PON2
49  2020 Recurrent HNSCC Harbor an Immunosuppressive Tumor Immune Microenvironment Suggesting Successful Tumor Immune Evasion. CRT, DC, HNSCC, rT, TIL, TIME, VD
50  2020 SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness. ESCC, HIF-1alpha, SETD5
51  2020 Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma. DM, HNSCC
52  2019 ALK mutation dynamics and clonal evolution in a neuroblastoma model exhibiting two ALK mutations. BM
53  2019 Association between KRAS G13D mutations and anastomotic recurrence in colorectal cancer: Two case reports. AR, CRC, MSI
54  2019 Biomaterial Scaffolds Recruit an Aggressive Population of Metastatic Tumor Cells In Vivo. LUNG, SCAF
55  2019 Combined CT radiomics of primary tumor and metastatic lymph nodes improves prediction of loco-regional control in head and neck cancer. HNC, LN, LRC, RCT
56  2019 Detection of ESR1 Mutations in Single Circulating Tumor Cells on Estrogen Deprivation Therapy but Not in Primary Tumors from Metastatic Luminal Breast Cancer Patients. CTCs, EDT, LBD
57  2019 Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their origin. CgA, GEP-NEN, MTS, sst
58  2019 Efficacy and safety of CT-guided high-dose-rate interstitial brachytherapy in primary and secondary malignancies of the pancreas. GTV, iLR, LTC, OS, PFS
59  2019 Intravoxel incoherent motion diffusion-weighted imaging for oropharyngeal squamous cell carcinoma: Correlation with human papillomavirus Status. ADC, IVIM-DWI, LN, OPSCC
60  2019 LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma. GA, IHC, LETM1, OS
61  2019 Lymph Node Response to Neoadjuvant Chemotherapy as an Independent Prognostic Factor in Metastatic Esophageal Cancer. CI, EC, HR, LN, NACT, RFS
62  2019 Molecular Characterization of Locally Relapsed Head and Neck Cancer after Concomitant Chemoradiotherapy. CNAs, HNSCC, LR
63  2019 Multiple oral cancer development-Clinico-pathological features in the Hong Kong population. HA, SCC
64  2019 Optimal sampling of pelvic lymphadenectomy specimens following radical prostatectomy: is complete tissue submission justified? LN, PLND
65  2019 Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy. HNSCC, LN, LR, TF, TLG-LN
66  2019 Predictors of survival and recurrence after primary surgery for cervical metastasis of unknown primary. CUP, DFS, HPV, LN, OS, SCCUP
67  2019 SBRT combined with concurrent chemoradiation in stage III NSCLC: Feasibility study of the phase I Hybrid trial. EPID, FRT, LN
68  2019 Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry). MBC, OS
69  2019 Transcriptional profiling of long-intergenic noncoding RNAs in lung squamous cell carcinoma and its value in diagnosis and prognosis. lincRNAs, LSQCC, SN
70  2018 Aggressive Phenotype of Cells Disseminated via Hematogenous and Lymphatic Route in Breast Cancer Patients. CSCs, CTCs, EMT, LNM
71  2018 B7H4 is associated with stemness and cancer progression in esophageal squamous cell carcinoma. CSC, ESCC
72  2018 Biomaterial Scaffolds as Pre-metastatic Niche Mimics Systemically Alter the Primary Tumor and Tumor Microenvironment. PMN, TAMs, TME
73  2018 Consolidated mathematical growth model of the primary tumor and secondary distant metastases of breast cancer (CoMPaS). BC, MTS
74  2018 CXCR4 and its ligand CXCL12 display opposite expression profiles in feline mammary metastatic disease, with the exception of HER2-overexpressing tumors. FMC
75  2018 High expression of CCL2 in tumor cells and abundant infiltration with CD14 positive macrophages predict early relapse in breast cancer. IHC, TAM
76  2018 High-Risk TP53 Mutations Are Associated with Extranodal Extension in Oral Cavity Squamous Cell Carcinoma. ENE, LN, OSCC, WT
77  2018 I-123-MIBG scintigraphy in patients with neuroblastoma. LN, NB, SPECT
78  2018 Strong expression of Id-1 in metastatic lymph nodes from esophageal squamous cell carcinoma is associated with better clinical outcome. ESCC, ID1, IHC, PMLN
79  2018 Updates in Pathologic Staging and Histologic Grading of Renal Cell Carcinoma. ---
80  2018 Vasculogenic mimicry and expression of ALDH1, Beclin1, and p16 correlate with metastasis and prognosis in oral squamous cell carcinoma. LNM, OS, OSCC, TNM, VM
81  2017 Association between miR-31-3p expression and cetuximab efficacy in patients with KRAS wild-type metastatic colorectal cancer: a post-hoc analysis of the New EPOC trial. CT, CTX, LM, WT
82  2017 Cbl-b predicts postoperative survival in patients with resectable pancreatic ductal adenocarcinoma. Cbl-b, OS, PDAC, pN, pTNM
83  2017 Correlation of 18F-FDG PET/CT with pathological features and survival in primary breast cancer. ---
84  2017 E2F1 Signalling is Predictive of Chemoresistance and Lymphogenic Metastasis in Penile Cancer: A Pilot Functional Study Reveals New Prognostic Biomarkers. NM, PC
85  2017 Effect of variations in atelectasis on tumor displacement during radiation therapy for locally advanced lung cancer. AT, BB, COM, CT
86  2017 EphA4 protein promotes invasion in clear cell renal cell carcinomas. ccRCC, EphA4, TNM
87  2017 Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancer. BCSS, DFS, ENE, LN, PD-ENE, TD-MET
88  2017 Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma. cfDNA, GEA, PANGEA
89  2017 Histopathologic Evolution of Urothelial Carcinoma Recurrence in Transurethral Resection of the Urinary Bladder:35 Consecutive Cases And Literature Review UC
90  2017 Identification of Changes in the Human Papilloma Virus 16 (HPV16) Genome During Early Dissemination of Cervical Cancer Cells May Complement Histological Diagnosis of Lymph Node Metastasis. BP, CACX, HPV-16, LN, LNs
91  2017 Is post-treatment standardized uptake value a prognostic factor in unresectable non-small cell lung carcinoma? CRT, NSCLC
92  2017 Keratin 7 expression in lymph node metastases but not in the primary tumour correlates with distant metastases and poor prognosis in colon carcinoma. CRC, LNM, OS
93  2017 Local recurrences at the anastomotic area are clonally related to the primary tumor in sporadic colorectal carcinoma. AR, DM, MSS
94  2017 MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy. HNSCC, LNM, MAGE, MEI, OS, RD, TMA
95  2017 Planning study for Merkel cell carcinoma based on the relapse pattern. CI, CN, CTV, HI, IT, RT
96  2017 Predictors of relapse and evaluation of the role of postoperative radiation therapy in a modern series of patients with surgically resected stage III (N2) non-small cell lung cancer. HR, LRC, NSCLC, OS, PORT
97  2017 Preoperative 68Ga-DOTA-Somatostatin Analog-PET/CT Hybrid Imaging Increases Detection Rate of Intra-abdominal Small Intestinal Neuroendocrine Tumor Lesions. CECT, PC, SI-NETs
98  2017 Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tract. HR, SULF1, UC, UTUC
99  2017 Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma. AT, HCC, RGC
100  2016 Apparent diffusion coefficient (ADC) change on repeated diffusion-weighted magnetic resonance imaging during radiochemotherapy for non-small cell lung cancer: A pilot study. ADC, DW-MRI, LN, NSCLC